Meta AnalysisID 4682

酒精中毒中色氨酸分解代谢物的变化:系统评价与Meta分析

CRD42022357640

Growing evidence suggests an abnormal catabolism of tryptophan in alcoholic people. However, these studies were conducted in different time periods and there is a great variation in study designs. Conflicting results hav

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
4682
Evidence Id
13240
Core Evidence Id
13240
Source Meta Analysis Id
4649
Herb2 Meta Analysis Id
HBMA004649
Crd Id
CRD42022357640
Title
Tryptophan catabolite changes in alcoholism: a systematic review and meta-analysis
Review Question
Growing evidence suggests an abnormal catabolism of tryptophan in alcoholic people. However, these studies were conducted in different time periods and there is a great variation in study designs. Conflicting results have also been found between studies. This systematic review and meta-analysis aimed at assessing the possible differences in tryptophan catabolites between alcoholic individuals and controls.
Study Type Included
Eligible studies were those: (1) observational studies including subjects with alcoholism, alcohol use disorder, alcohol dependence, alcohol withdrawal syndrome or hazardous drinking, diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders (DSM), the International Classification of Diseases (ICD) criteria, Alcohol Use Disorders Identification Test or reviewed by specialist; (2) with non-alcoholic controls; (3) detecting at least one of tryptophan catabolites, including tryptophan, serotonin, kynurenine, kynurenic acid, quinolinic acid, 3-hydroxykynurenine, 5-hydroxyindoleacetic acid and ratios of these metabolites; (4) measuring concentrations of these compounds in human plasma, serum, cerebrospinal fluid or urine; (5) reported detailed data in the abstract or full text of papers. No restriction was made on the publication year or on the language of the papers. Studies that reported repeated data, or those full text or abstract was not available, or did not include detailed data, were excluded.
Condition Being Studied
Alcohol is the most extensive addictive substance in the world. The harmful use of alcohol causes increasing concern on the personal and public health, which results in more than 3.3 million deaths every year. Alcohol use disorder is highly comorbid with mental and physical diseases. The pathophysiology of alcohol use disorder remains to be fully elucidated but accumulating evidence have shown abnormal tryptophan catabolism in alcoholics.
Participant
Patients diagnosed with alcoholism, alcohol use disorder, alcohol dependence, alcohol withdrawal syndrome or hazardous drinking were used. The diagnosis criteria should be the Diagnostic and Statistical Manual of Mental Disorders, the International Classification of Diseases criteria, Alcohol Use Disorders Identification Test or carefully reviewed by an specialist.
Animal
Human Disease Modelled
Intervention
Baseline concentrations or ratios of tryptophan metabolites in blood, CSF and urine in alcoholics and controls were extracted. For study presenting patient groups with comorbidity such as depression and hepatic disease, only data of patients without accompanying disease was used.
Comparator Control
non-alcoholic control group
Main Outcome
Seperate meta-analyses are conducted to measure concentrations of tryptophan metabolites in blood, cerebrospinal fluid or urine of alcoholics compared to non-alcoholic controls. The names of metabolites have been provided in item 22. Measures of effect Pooled outcomes of mean differences and 95% confidence interval in these metabolites were estimated in separate meta-analyses. For metabolite in urine, standard mean difference estimated by Hedges' g was adopted because of the various units between studies.
Outcome Measure
Additional Outcome
No
Study Method
Meta-analysis, Systematic review
Keyword
Alcoholism; Humans; Tryptophan
Contact
Zhanzhang Wang [email protected]
Organisational Affiliation
Guangzhou Medical University Affilated Brain Hospital
Funding Source
This work was supported by the Natural Science Foundation of Guangdong Province (grant number 2021A1515011325), Science and Technology Plan Project of Guangzhou (grant number 202102080030, 202201010736), Scientific Research Project of Traditional Chinese Medicine Bureau of Guangdong Province (grant number 20222177), Science and Technology Plan Project of Guangdong Province (2019B0303160), and Guangzhou Municipal Key Discipline in Medicine (2021-2023). Grant number(s) <span style=font-size: 14px>State the funder, grant or award number and the date of award</span> 6
Other Selection Criteria
Final Publication
Same Topic Review
No existing review
Published Protocol
Review Type
Language
English
Country
China
Review Stage
Review Ongoing
First Submission Date
2022-09-03
Registration Date
2022-09-13
Anticipated Start Date
2022-08-01
Anticipated Completion Date
2022-10-04
Title Cn
酒精中毒中色氨酸分解代谢物的变化:系统评价与Meta分析
Title En
Tryptophan catabolite changes in alcoholism: a systematic review and meta-analysis
Bilingual Status
complete